Reduced-intensity conditioning allogeneic hematopoietic cell transplantation for patients with hematologic malignancies who relapse following autologous transplantation: a multi-institutional prospective study from the Cancer and Leukemia Group B (CALGB trial 100002).

Saved in:
Bibliographic Details
Title: Reduced-intensity conditioning allogeneic hematopoietic cell transplantation for patients with hematologic malignancies who relapse following autologous transplantation: a multi-institutional prospective study from the Cancer and Leukemia Group B (CALGB trial 100002).
Authors: Bashey A; University of California at San Diego, San Diego, CA, USA. abashey@bmtga.com, Owzar K, Johnson JL, Edwards PS, Kelly M, Baxter-Lowe LA, Devine S, Farag S, Hurd D, Ball E, McCarthy P, Lister J, Shea TC, Linker C
Source: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation [Biol Blood Marrow Transplant] 2011 Apr; Vol. 17 (4), pp. 558-65. Date of Electronic Publication: 2010 Jul 30.
Publication Type: Clinical Trial; Journal Article; Multicenter Study; Research Support, N.I.H., Extramural
Journal Info: Publisher: Carden Jennings Publishing Country of Publication: United States NLM ID: 9600628 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1523-6536 (Electronic) Linking ISSN: 10838791 NLM ISO Abbreviation: Biol Blood Marrow Transplant Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1523-6536
DOI:10.1016/j.bbmt.2010.07.015